Brian M DeBroff is an Professor, Department of Ophthalmology and Visual Science, Yale University School of Medicine. He grew up in Pittsburgh and attended Tufts University, graduating Magna Cum Laude in Biology and Classics. As a medical student at Tufts, he was inducted in Alpha Omega Alpha and The Sir William Osler Honor Society and was presented with the Sandoz Award and the Massachusetts Medical Society Research Award. After his Ophthalmology Residency at the Eye and Ear Institute at the University of Pittsburgh, he completed an Anterior Segment Surgery Fellowship at the Gimbel Eye Centre/University of Calgary in Calgary, Canada. He has also completed an Executive Management Program at the Yale University Business School and Yale University School of Public Health in 2000.
His publications include 2 books, eight book chapters, and over 40 articles in peer-reviewed journals. He has practiced Ophthalmology in Connecticut for the past 20 years, during which time he has been actively training Ophthalmology residents at the Yale University School of Medicine and has been the only Ophthalmologist to be presented with the Teaching Award twice (1998 and 2008). He has also served as the Residency Program Director and the Vice Chairman of the Department of Ophthalmology and Visual Science for 7 years (1999-2006). He continues to teach as Director of Cataract Medical Education and Wet Laboratory Training for the Yale University Residency Program (since 1994). He is also on the Resident Surgical Curriculum Committee.
From 1999-2006, He is also was the Director of the Cataract Eye Service at Yale University and the Director of Comprehensive Eye Services, Consultative Eye Services for Yale-New Haven Hospital, and Chairman of the Operating Room Committee. He has served on numerous academic committees, including: CME, Appointment and Promotions, Medical School Admissions, Facilities and Operations Design, Graduate Medical Education, Liaison Chair Search, Clinical Chiefs, Practice Advisory to the Dean, Strategic Advisory Committee for Yale Medical School, Best Practices, and the Dean’s Clinical Practice Planning Committee.
He is a Diplomate of the American Board of Ophthalmology and a Fellow of the American College of Surgeons. He is the Selection Chair for Ophthalmology applicants to the American College of Surgeons in Connecticut. He serves numerous editorial positions including Section Editor of Cataract Surgery Techniques for Techniques in Ophthalmology, and a Reviewer for: Archives of Ophthalmology, Journal of Cataract and Refractive Surgery, British Journal of Ophthalmology, Yale Journal of Biology and Medicine, Ocular Surgery News, Journal of Refractive Surgery, and the Ophthalmology Section of the Federal Practitioner.
His awards include: American Academy of Ophthalmology LEO Award, AAO Award for Federal Service, Plenary Award from the Diabetic Association of Bangladesh, Vision Leadership Award, Straatsma Award Nominee, Research Council of America Top Ophthalmologists (2001-2009), Castle Connolly’s Top Ophthalmologist (New York Metropolitan Area), and Best Doctors of America.
Research Interest
His area of expertise is Cataract Surgery. He performs the latest techniques of adult and pediatric cataract surgery, including complicated and traumatic anterior segment surgery. He has extensive experience and teaches other Ophthalmologists in performing Toric and Multifocal IOL procedures. He has lectured Nationally and Internationally regarding cataract surgery techniques and actively teaches and supervises Ophthalmology residents in performing cataract surgery.
Peter Van Patten trained as a neurologist and is a practicing ophthalmologist and eye surgeon. He holds a B.A. in Environmental Studies, is the founder of Celsprin LLC, and is the inventor of a novel treatment for prophylaxis of migraine using a Cox-2 inhibitor and aspirin (or active derivative). He has practiced ophthalmology including cataract surgery since 1991 and filed his first provisional patent application in August of 2000, leading to an issued patent in March of 2014. He filed his second provisional patent application in December of 2013 and founded Celsprin LLC (an intellectual property holding company) in March of 2014.
As a physician board certified in ophthalmology and neurology, he has more than 24 years of clinical and surgical experience and completed two full residency programs as well as a Transitional internship (including rotations in medical and surgical specialties).
He worked for Kaiser as an emergency room physician on weekends prior to completing his neurology residency. He then worked in the same Department for three months before joining Jackson and Coker as a full time Delaware-based locum tenens neurologist in September of 1987 prior to beginning his ophthalmology residency program in July of 1988.
After completing his second residency in 1991, he worked in private practice in Central Oregon for two years prior to becoming an Assistant Professor of Ophthalmology at Southern Illinois University School of Medicine in 1993 where he served on the Patents and Copyrights Committee.
In 1996, He joined the East Range Clinics as a staff ophthalmologist and was offered shareholder status two years later. After several months, the clinic merged with SMDC Health System which subsequently became Essentia Health. In 2006, he was invited to become a Board member of the Minnesota Academy of Ophthalmology where he served for six years. He also served as a Board member of the Range Medical Society from 1999 through 2013 and an alternate Delegate and Delegate to the Minnesota Medical Association annual meeting several times, serving on a Reference Committee (including open debate of proposed resolutions) at the Annual Meeting in September of 2011.
He enjoys fly fishing and other outdoor activities, is a fitness enthusiast, likes to travel, and is also proud to support his daughter Arabella’s equestrian and educational activities in northern Virginia (where she is a member of the Foxcroft School Equestrian team).
Research Interest
Novel methods; compositions involving Cox-2 inhibition; aspirin (or active derivative)
